SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-001845
Filing Date
2008-02-27
Accepted
2008-02-27 17:19:15
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2182965z10-k.htm 10-K 1212080
2 EXHIBIT 21.1 a2182965zex-21_1.htm EX-21.1 1556
3 EXHIBIT 23.1 a2182965zex-23_1.htm EX-23.1 2648
4 EXHIBIT 31.1 a2182965zex-31_1.htm EX-31.1 7081
5 EXHIBIT 31.2 a2182965zex-31_2.htm EX-31.2 7107
6 EXHIBIT 32.1 a2182965zex-32_1.htm EX-32.1 3367
7 EXHIBIT 32.2 a2182965zex-32_2.htm EX-32.2 3404
8 G99784.JPG g99784.jpg GRAPHIC 29475
9 G390710.JPG g390710.jpg GRAPHIC 2548
  Complete submission text file 0001047469-08-001845.txt   1283170
Mailing Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14732 | Film No.: 08647496
SIC: 2835 In Vitro & In Vivo Diagnostic Substances